Stay updated on Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2. This update appears to be a metadata change with no impact on study details.
    Difference
    0.1%
    Check dated 2025-11-24T21:29:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The general government funding status notice related to NIH operations has been removed, but this does not affect the study details, eligibility, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T19:22:45.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The update appears to be limited to minor layout and formatting adjustments on the study page; core details like inclusion criteria, outcomes, and participating sites remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T13:44:04.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T04:14:51.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Updated to Revision: v3.1.0 with expanded contact details; old Revision: v3.0.2 removed.
    Difference
    0.1%
    Check dated 2025-09-28T23:34:25.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element. No other substantive changes to core content, pricing, stock, or time-slot availability.
    Difference
    0.2%
    Check dated 2025-09-14T09:52:43.000Z thumbnail image

Stay in the know with updates to Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib in 2nd-line Biliary AdenoCa Clinical Trial page.